<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Esparza</surname>
    <given-names>T. J.</given-names>
   </name>
   <name>
    <surname>Martin</surname>
    <given-names>N. P.</given-names>
   </name>
   <name>
    <surname>Anderson</surname>
    <given-names>G. P.</given-names>
   </name>
   <name>
    <surname>Goldman</surname>
    <given-names>E. R.</given-names>
   </name>
   <name>
    <surname>Brody</surname>
    <given-names>D. L.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme</article-title>. 
  <source>Sci. Rep.</source>
  <volume>10</volume> (
  <issue>1</issue>), 
  <fpage>22370</fpage>. 
  <pub-id pub-id-type="doi">10.1038/s41598-020-79036-0</pub-id>
  <pub-id pub-id-type="pmid">33353972</pub-id>
 </mixed-citation>
</ref>
